DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Dodick DW, Goadsby PJ, Spierings ELH et al.
Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study.
Lancet Neurol 2014;
13: 885-892
We do not assume any responsibility for the contents of the web pages of other providers.